Search

everythinglearnresearchcommunity

for

Search:↓

The new drug delivery system effectively targets lung cancer cells.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.